BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27184479)

  • 1. Frequent PIK3CA-activating mutations in hidradenoma papilliferums.
    Liau JY; Lan J; Hong JB; Tsai JH; Kuo KT; Chu CY; Sheen YS; Huang WC
    Hum Pathol; 2016 Sep; 55():57-62. PubMed ID: 27184479
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Goto K; Maeda D; Kudo-Asabe Y; Hibiya T; Hayashi A; Fukayama M; Ohashi K; Goto A
    J Clin Pathol; 2017 May; 70(5):424-427. PubMed ID: 27742746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in genes encoding PI3K-AKT and MAPK signaling define anogenital papillary hidradenoma.
    Pfarr N; Sinn HP; Klauschen F; Flechtenmacher C; Bockmayr M; Ridinger K; von Winterfeld M; Warth A; Lorenz K; Budczies J; Penzel R; Lennerz JK; Endris V; Weichert W; Stenzinger A
    Genes Chromosomes Cancer; 2016 Feb; 55(2):113-9. PubMed ID: 26493284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Several genotypes, one phenotype: PIK3CA/AKT1 mutation-negative hidradenoma papilliferum show genetic lesions in other components of the signalling network.
    Pfarr N; Allgäuer M; Steiger K; Weichert W; Schirmacher P; Noske A; Stenzinger A
    Pathology; 2019 Jun; 51(4):362-368. PubMed ID: 31010589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AKT1 E17K in Colorectal Carcinoma Is Associated with BRAF V600E but Not MSI-H Status: A Clinicopathologic Comparison to PIK3CA Helical and Kinase Domain Mutants.
    Hechtman JF; Sadowska J; Huse JT; Borsu L; Yaeger R; Shia J; Vakiani E; Ladanyi M; Arcila ME
    Mol Cancer Res; 2015 Jun; 13(6):1003-8. PubMed ID: 25714871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular alterations in lesions of anogenital mammary-like glands and their mammary counterparts including hidradenoma papilliferum, intraductal papilloma, fibroadenoma and phyllodes tumor.
    Konstantinova AM; Vanecek T; Martinek P; Kyrpychova L; Spagnolo DV; Stewart CJR; Portelli F; Michal M; Kazakov DV
    Ann Diagn Pathol; 2017 Jun; 28():12-18. PubMed ID: 28648934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vulvar hidradenoma papilliferum (HP) is located on the sites of mammary-like anogenital glands (MLAGs): Analysis of the photographs of 52 tumors.
    El-Khoury J; Renald MH; Plantier F; Avril MF; Moyal-Barracco M
    J Am Acad Dermatol; 2016 Aug; 75(2):380-4. PubMed ID: 26944596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent PIK3CA activating mutations in nipple adenomas.
    Liau JY; Lee YH; Tsai JH; Yuan CT; Chu CY; Hong JB; Sheen YS
    Histopathology; 2017 Jan; 70(2):195-202. PubMed ID: 27441415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hidradenoma Papilliferum: A Clinicopathologic Study of 264 Tumors From 261 Patients, With Emphasis on Mammary-Type Alterations.
    Konstantinova AM; Michal M; Kacerovska D; Spagnolo DV; Stewart CJ; Kutzner H; Zelger B; Plaza JA; Denisjuk N; Hejda V; Shelekhova K; Bisceglia M; Danis D; Zamecnik M; Kerl K; Guenova E; Kazakov DV
    Am J Dermatopathol; 2016 Aug; 38(8):598-607. PubMed ID: 26863059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRAF and KRAS mutations in tubular apocrine adenoma and papillary eccrine adenoma of the skin.
    Liau JY; Tsai JH; Huang WC; Lan J; Hong JB; Yuan CT
    Hum Pathol; 2018 Mar; 73():59-65. PubMed ID: 29241739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hidradenoma papilliferum of the vulva: case report and review of literature.
    Duhan N; Kalra R; Singh S; Rajotia N
    Arch Gynecol Obstet; 2011 Oct; 284(4):1015-7. PubMed ID: 21132312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast.
    Troxell ML; Levine J; Beadling C; Warrick A; Dunlap J; Presnell A; Patterson J; Shukla A; Olson NR; Heinrich MC; Corless CL
    Mod Pathol; 2010 Jan; 23(1):27-37. PubMed ID: 19898424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.
    Juanpere N; Agell L; Lorenzo M; de Muga S; López-Vilaró L; Murillo R; Mojal S; Serrano S; Lorente JA; Lloreta J; Hernández S
    Hum Pathol; 2012 Oct; 43(10):1573-82. PubMed ID: 22417847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hidradenoma papilliferum of the vulva in association with an anogenital mammary-like gland.
    Kurashige Y; Kishida K; Kurashige K; Minemura T; Nagatani T
    J Dermatol; 2014 May; 41(5):411-3. PubMed ID: 24617304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of KRAS, BRAF and PIK3CA mutational status in 209 consecutive Italian colorectal cancer patients.
    Bozzao C; Varvara D; Piglionica M; Bagnulo R; Forte G; Patruno M; Russo S; Piscitelli D; Stella A; Resta N
    Int J Biol Markers; 2012 Dec; 27(4):e366-74. PubMed ID: 23125007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenomyoepitheliomas of the Breast Frequently Harbor Recurrent Hotspot Mutations in PIK3-AKT Pathway-related Genes and a Subset Show Genetic Similarity to Salivary Gland Epithelial-Myoepithelial Carcinoma.
    Lubin D; Toorens E; Zhang PJ; Jaffer S; Baraban E; Bleiweiss IJ; Nayak A
    Am J Surg Pathol; 2019 Jul; 43(7):1005-1013. PubMed ID: 31094929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of Selected BRCA1, BRCA2, and PIK3CA Mutations in Benign and Malignant Lesions of Anogenital Mammary-Like Glands.
    Konstantinova AM; Shelekhova KV; Imyanitov EN; Iyevleva A; Kacerovska D; Michal M; Kazakov DV
    Am J Dermatopathol; 2017 May; 39(5):358-362. PubMed ID: 28291131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juvenile papillomatosis of the breast (Swiss cheese disease) has frequent associations with PIK3CA and/or AKT1 mutations.
    Guillet C; Rechsteiner M; Bellini E; Choschzick M; Moskovszky L; Dedes K; Papassotiropoulos B; Varga Z
    Hum Pathol; 2020 Apr; 98():64-73. PubMed ID: 32088208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of KRAS, NRAS, PIK3CA, and BRAF mutational profile in poorly differentiated clusters of KRAS-mutated colon cancer.
    Reggiani Bonetti L; Barresi V; Bettelli S; Caprera C; Manfredini S; Maiorana A
    Hum Pathol; 2017 Apr; 62():91-98. PubMed ID: 28025078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A composite neoplastic lesion of the vulva with mixed features of fibroadenoma and hidradenoma papilliferum combined with pseudoangiomatous stromal hyperplasia containing multinucleated giant cells.
    Konstantinova AM; Kacerovska D; Michal M; Kazakov DV
    Am J Dermatopathol; 2014 Oct; 36(10):e171-4. PubMed ID: 23503319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.